Free Trial

Kyntra Bio (KYNB) Institutional Ownership

Kyntra Bio logo
$7.03 +0.18 (+2.63%)
As of 01:11 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Kyntra Bio (NASDAQ:KYNB)

Current
Institutional Ownership
Percentage
72.71%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$257.30K
Number of
Institutional Sellers
(last 12 months)
0
Get KYNB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kyntra Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Kyntra Bio Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2026 ADAR1 Capital Management LLC10,469$71K0.0%N/A0.258%
5/14/2026 Renaissance Technologies LLC27,481$186K0.0%N/A0.679%


KYNB Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Kyntra Bio shares: Renaissance Technologies LLC ($186K), ADAR1 Capital Management LLC ($71K).Learn more on Kyntra Bio's institutional investors.

72.71% of Kyntra Bio's stock is owned by institutional investors. Learn more on KYNB's institutional investor holdings.

The following institutional investors have purchased Kyntra Bio's stock in the last 24 months: Renaissance Technologies LLC ($27.48K), and ADAR1 Capital Management LLC ($10.47K).

Institutional investors have bought a total of 37,950 shares in the last 24 months. This purchase volume represents approximately $257.30K in transactions.



This page (NASDAQ:KYNB) was last updated on 5/27/2026 by MarketBeat.com Staff.
From Our Partners